Relation of Free PSA/Total PSA in Serum for Differentiating Between Patients with Prostatic Cancer and Benign Hyperplasia of the Prostate: Which Cutoff Should Be Used?-Reference-Cited by-同舟云学术

Relation of Free PSA/Total PSA in Serum for Differentiating Between Patients with Prostatic Cancer and Benign Hyperplasia of the Prostate: Which Cutoff Should Be Used?

Published:1998-01 Issue:1 Volume:16 Page:45-49
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Lein M.,Stephan C.,Jung K.,Schnorr D.,Loening S.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/07357909809039753

Reference30 articles.

1. Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and Ratios

2. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening

3. Clinical usefulness of free and complexed PSA

4. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biópsia De Próstata Guiada Por Ultrassonografia De Fusão: Experiência De Uma Clínica Particular Da Cidade De Bragança Paulista;Journal of Medical Residency Review;2023-11-27

2. Voice Analysis in Men with Benign Prostate Hyperplasia;Cukurova Anestezi ve Cerrahi Bilimler Dergisi;2023-09-15

3. Age-Specific Percentile-based Prostate-Specific Antigen Cutoff Values Predict the Risk of Prostate Cancer: a single hospital observation;BioMedicine;2023-08-28

4. Clinical efficacy of prostate PI-RADS V2.1 score combined with serum PSA-related indicators in the detection of gray zone prostate cancer;International Urology and Nephrology;2023-07-31

5. Development and preliminary evaluation of an integrin α2β1-targeted PET probe as a supplement and alternative of PSMA imaging for prostate cancer;Bioorganic & Medicinal Chemistry;2022-01